BIO-key International, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.3M | $3.0M | $5.3M | $4.0M | $2.0M | $3.8M | $3.5M | $3.5M |
| Cost of Revenue | $3.2M | $729.7K | $1.3M | $748.8K | $387.0K | $571.7K | $810.5K | $559.1K |
| Gross Profit | $3.1M | $2.2M | $4.0M | $3.3M | $1.6M | $3.3M | $2.7M | $3.0M |
| Gross Margin | 48.6% | 75.5% | 75.7% | 81.3% | 80.5% | 85.1% | 76.9% | 84.1% |
| Operating Expenses | ||||||||
| Research & Development | $1.7M | $2.0M | $1.6M | $1.6M | $1.3M | $947.4K | $1.1M | $1.1M |
| SG&A Expense | $5.7M | $4.4M | $4.1M | $3.7M | $2.8M | $2.3M | $3.0M | $3.1M |
| Operating Income | $-4.3M | $-4.2M | $-1.7M | $-2.0M | $-2.5M | $27.9K | $-1.5M | $-1.2M |
| Operating Margin | -67.8% | -141.2% | -32.2% | -50.9% | -127.0% | 0.7% | -41.5% | -34.1% |
| Interest Expense | — | — | $192.2K | — | $136.5K | $24.6K | $411.5K | $711.3K |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | $0 | $-12.1K | $161.0K | $1.7K | $2.8K | — | $26.5K | — |
| Net Income | $-4.3M | $-4.2M | $-1.9M | $-1.9M | $-2.6M | $3.3K | $-1.9M | $-306.8K |
| Net Margin | -67.8% | -140.8% | -35.3% | -47.0% | -130.0% | 0.1% | -54.1% | -8.7% |
| EPS (Basic) | $-0.25 | $-0.30 | $-0.12 | $-0.01 | $-0.02 | $0.00 | $-0.01 | $0.00 |
| EPS (Diluted) | $-0.25 | $-0.30 | $-0.12 | $-0.01 | $-0.02 | $0.00 | $-0.01 | $0.00 |
| Shares Outstanding (Basic) | 23.1M | 18.3M | 16.5M | 198.0M | 173.8M | 234.5M | 234.5M | 234.5M |
| Shares Outstanding (Diluted) | 23.1M | 18.3M | 16.5M | 198.0M | 173.8M | 234.5M | 234.5M | 234.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |